Apelin could have a protective effect on peripheral nerves and may be used as a risk indicator for the early detection of DPN in T2DM subjects, as well as to evaluate the effect of antihyperglycemic and neurotrophic treatments on T2DM subjects with DPN. Here, APLN is linked to type 2 diabetes mellitus.